Intelligent Intensive Care Unit

NCT02465307 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-06-29

No results posted yet for this study

Summary

Delirium, as a common complication of hospitalization, poses significant health problems in hospitalized patients. Though about a third of delirium cases can benefit from intervention, detecting and predicting delirium is still very limited in practice. A common characterization of delirium is change in activity level, causing patients to become hyperactive or hypoactive which is manifested in facial expressions and total body movements. This pilot study is designed to test the feasibility of a delirium detection system using movement data obtained from 3-axis wearable accelerometers and commercially available camera with facial recognition video system in conjunction with electronics medical record (EMR) data to analyze the relation of whole-body movement and facial expressions with delirium.

Conditions

Interventions

BEHAVIORAL

Confusion Assessment Method

Confusion Assessment Method (CAM) score

DEVICE

Accelerometer

3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor

DEVICE

Commercially available camera

As part of facial recognition video system

DEVICE

Internet Pod (iPod)

Monitors noise levels in the room

DIAGNOSTIC_TEST

Cortisol Swab

Cortisol level collected through self administered salivary swab

Sponsors & Collaborators

  • U.S. National Science Foundation

    collaborator FED
  • National Institute for Biomedical Imaging and Bioengineering (NIBIB)

    collaborator NIH
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • University of Florida

    lead OTHER

Principal Investigators

  • Azra Bihorac, MD · University of Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2020-03-11
Completion
2028-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465307 on ClinicalTrials.gov